«The addition of
osteocalcin as a metabolic regulator may one day lead to novel therapies, but we need to understand much better how it
works and how it fits into physiology before such therapies can be attempted in humans,» says endocrinologist Mitch Lazar, director of the Institute for Diabetes, Obesity, and Metabolism at the University of Pennsylvania.